VDP Pharmacy Enrollment

Dec. 22, 2015: All new and currently-enrolled pharmacy providers that want to participate in VDP and in managed care networks are required to enroll using the VDP Pharmacy Provider Enrollment Application.  Our frequently asked questions document is updated weekly.  Completed application packets may be mailed to HHSCMore about the pharmacy enrollment process.

TMHP Prescriber Enrollment

Dec. 22, 2015: VDP will reject fee-for-service prescription claims that include a National Provider Identifier (NPI) of a non-enrolled prescriber.  Beginning March 24, 2016, fee-for-service claims may reject if the prescriber is not re-enrolled.  More about the TMHP prescriber enrollment.

What We Do

The Medicaid/CHIP Vendor Drug Program:

  • Enrolls pharmacy providers that want to provide Medicaid and CHIP services;
  • Manages the State of Texas Medicaid and CHIP formularies;
  • Processes out-patient pharmacy prescription claims for Medicaid fee-for-service, the Texas Women's Health Program, the DSHS Children with Special Health Care Needs (CSHCN) Services Program, and the DSHS Kidney Health Care (KHC) program.

Continuing Education

Watch these multi-part guides to learn about dispensing Texas Medicaid prescriptions, DME, and pharmacy prior authorization:

training videos for pharmacists

Training videos for pharmacy staff 

Chapters include Obtaining a Prior Authorization, Dispensing a 72-hour emergency supply, Confirming eligibility, and Durable medical equipment.

training videos for physicians

Training videos for physicians

Chapters include Preferred Drug List, E-Prescribing (E-Rx), and 72-hour Emergency Prescription Claims.

News Highlights

Electronic Prescribing of Controlled Substance Allowed In Texas

October 26, 2015

Over 85 percent of Texas pharmacies have the capability for Electronic Prescribing of Controlled Substances (EPCS) prescriptions. Unfortunately, less than 3 percent of Texas prescribers are using EPCS. More about HHSC's state-wide EPCS campaign.

Changes Coming to DUR Board in 2016

September 21, 2015

HHSC will consolidate the Drug Utilization Review Board and Pharmaceutical & Therapeutics Committee into one, 17-member committee comprised of both pharmacists and providers, 2 non-voting representatives from managed care organizations, and 1 one consumer advocate.  The new DUR board will meet in spring 2016.  More about the new advisory board.